CMSC: Real-World Study Confirms Dimethyl Fumarate Safety
GI disorders most common reason for Tx discontinuation Safety is always a concern for any...
Read More
BreakingMed
International Working Group: Biomarkers Alone Not Enough for Alzheimer’s Dx
Recommendations from IWG stress importance of merging clinical and biomarker criteria The...
Read More
Ozanimod for Relapsed MS: Researchers Confirm Safety of Recently Approved S1P Modulator
Continued use of ozanimod for RMS brings no new safety concerns Longer duration of treatment with...
Read More
Some MS Drugs Attenuate Covid-19 Vaccine Response
Vaccination timing, additional doses merit consideration MS patients should receive Covid-19...
Read More
CMSC: Most MS Providers Think Diroximel Fumarate Has Better GI Profile
Prescribers cite tolerability when switching from other DMTs For those who doubt the effectiveness...
Read More
Moderate Support for Anti-Amyloid Alzheimer’s Drugs in Meta-Analysis
Small clinical improvements, large biomarker changes, and major risk for ARIA Finding an effective...
Read More
Alzheimer’s Disease: FDA Rolls Out Prescribing Information for Aducanumab
Experts discuss the just-approved monoclonal antibody amid ongoing controversy “Be careful...
Read More
AAIC: Donanemab Tx Reduced Levels of the Alzheimer’s Biomarker P-Tau217
Biomarker reduction correlates with decrease in beta-amyloid An investigational monoclonal...
Read More
In a No Holds Barred Statement, the American Academy of Neurology Offers Advice for Members on Prescribing Aducanumab
AAN statement leaves little to the imagination In response to the controversy concerning...
Read More
Despite Higher CV Risk Burden in Black Patients, CVD and Event Rates Are Lower
PROMISE trial: Compared with White patients, Blacks patients had low rates of epicardial CAD While...
Read More
Covid-19: Metabolic Syndrome Linked to Greater ARDS, Death in Hospitalized Patients
In global study, risk increased for every additional metabolic syndrome symptom present Having...
Read More
FDA Approves Add-On Inclisiran to Lower LDL-C in Patients with Hypercholesterolemia/ASCVD
Subcutaneous injection to be used alongside diet and statin therapy The FDA approved subcutaneous...
Read More
FDA Authorizes Second Pill for Covid-19
EUA says molnupiravir should be last choice when other Tx is not available The FDA made...
Read More
Lower-Sodium Oxybate Shows Benefit in Idiopathic Hypersomnia
Newly approved treatment improves scores on sleepiness scale Lower-sodium oxybate showed efficacy...
Read More
BreakingMED Year-End Review Starts Monday, December 27
Each day offers opportunity for 2.5 CME/CE credits As we near the end of year two of the Covid-19...
Read More
Spouses Share More Than Love—They May Share Dementia, Too
Factors couples share may mediate spousal risk for cognitive disorders Older adults were more...
Read More
Investigational Spesolimab Proves Mettle in Generalized Pustular Psoriasis
IL-36 receptor inhibitor led to lesion clearance at one week in phase II trial Treatment with IV...
Read More
Covid-19: Early Treatment with Remdesivir Reduces Hospitalization
87% reduction in hospitalization, death reported in PINETREE trial Early treatment with the...
Read More
Thyroid Lobectomy Bests Total Thyroidectomy for HRQOL
The question could be asked: Why use total thyroidectomy at all? Patients with differentiated...
Read More
FDA OKs Injectable Cabotegravir for HIV PrEP
Injectable option lets patients forego daily pill The FDA approved an extended-release injectable...
Read More